Manufacturing, latest filing in February 2026

Aebi Schmidt Holding Ag

Aebi Schmidt Holding Ag has 5 Schedule 13D or 13G filings on record since 2025-08-14. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Aebi Schmidt Holding Ag, with its principal executive office as SCHULSTRASSE 4, FRAUENFELD (SCHEDULE 13G/A, 2026-02-17).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc. has 1 Schedule 13D or 13G filing on record since 2026-02-13. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Anebulo Pharmaceuticals, Inc., with its principal executive office as 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX 78734 (SCHEDULE 13G/A, 2026-02-13).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Australian Oilseeds Holdings Ltd

Australian Oilseeds Holdings Ltd has 2 Schedule 13D or 13G filings on record since 2025-12-10. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Australian Oilseeds Holdings Ltd, with its principal executive office as 126-142 COWCUMBLA STREET, COOTAMUNDRA (SCHEDULE 13G/A, 2026-02-13).

Aggregate - 6.27%; see also Item 11 on the cover page for each Reporting Person. The percentages of beneficial ownership contained herein are based on 27,898,540 ordinary shares outstanding as of December 4, 2025, per the issuers Form F-1 dated December 4, 2025.Arena Investors LP, SCHEDULE 13G/A, 2026-02-13

Swipe the table sideways to see every column.

Celestica Inc

Celestica Inc has 3 Schedule 13D or 13G filings on record since 2025-08-14. 2 holders' latest filing reports 5% or more of common shares. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Celestica Inc, with its principal executive office as 5140 YONGE STREET, SUITE 1900, TORONTO (SCHEDULE 13G/A, 2026-02-05).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. has 2 Schedule 13D or 13G filings on record since 2025-10-30. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Cumberland Pharmaceuticals Inc., with its principal executive office as 1600 West End Avenue, Suite 1300, Nashville, TN 37203 (SCHEDULE 13G, 2026-02-09).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

CVR Energy, Inc.

CVR Energy, Inc. has 4 Schedule 13D or 13G filings on record since 2025-07-16. 1 holder's latest filing reports 5% or more of common stock, par value $0.01. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies CVR Energy, Inc. by CUSIP 12662P108 and gives its principal executive office as 2277 Plaza Drive, Suite 500, Sugar Land, TX 77479 (SCHEDULE 13D/A, 2026-11-06).

Carl C Icahn

Item 4 of the Initial 13D is hereby amended and supplemented by adding the following: On November 3, 2026, the Issuer entered into an underwriting agreement (the "Underwriting Agreement") with Barclays Capital Inc. and Jefferies LLC, as representatives (the "Representatives") of the several underwriters named therein (the "Underwriters"), relating to the offering of 10,515,248 Shares at a public offering price of $47.55 per Share (the "Equity Offering"). The Issuer also granted the Underwriters a 30-day option to purchase up to 1,577,287 additional Shares from the Issuer. The Equity Offering closed on November 5, 2026. The Reporting Persons and their affiliates did not sell Shares as selling stockholders in the Equity Offering. In connection with the Equity Offering, on November 3, 2026, American Entertainment Properties Corp. and IEP Energy Holding LLC, each an indirect wholly owned subsidiary of Icahn Enterprises Holdings L.P., each entered into customary lock-up letter agreements with the Representatives for a period of 30 days, subject to customary exceptions (the "Lock-Up Agreements").Item 4 of the SCHEDULE 13D/A filed 2026-11-06

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Cytosorbents Corp

Cytosorbents Corp has 1 Schedule 13D or 13G filing on record since 2026-02-13. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Cytosorbents Corp, with its principal executive office as 305 COLLEGE ROAD EAST, PRINCETON, NJ 08540 (SCHEDULE 13G/A, 2026-02-13).

Swipe the table sideways to see every column.

Dynatronics Corp

Dynatronics Corp has 2 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Dynatronics Corp, with its principal executive office as 7030 PARK CENTRE DRIVE, BLDG D, SALT LAKE CITY, UT 84121 (SCHEDULE 13G/A, 2026-02-17).

Swipe the table sideways to see every column.

Dynavax Technologies Corporation

Dynavax Technologies Corporation has 3 Schedule 13D or 13G filings on record since 2025-07-17. 1 holder's latest filing reports 5% or more of common stock, $0.001 par value. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Dynavax Technologies Corporation, with its principal executive office as 2100 Powell Street, Suite 720, Emeryville, CA 94608 (SCHEDULE 13G/A, 2026-02-11).

Swipe the table sideways to see every column.

Electrovaya Inc

Electrovaya Inc has 5 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Electrovaya Inc by CUSIP 28617B606 and gives its principal executive office as 6688 KITIMAT ROAD, MISSISSAUGA (SCHEDULE 13G/A, 2026-11-05).

Swipe the table sideways to see every column.

Flexible Solutions International, Inc.

Flexible Solutions International, Inc. has 1 Schedule 13D or 13G filing on record since 2026-02-11. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Flexible Solutions International, Inc. by CUSIP 33938T104 and gives its principal executive office as 6001 54 Ave., Taber (SCHEDULE 13D/A, 2026-02-11).

Daniel B. O'Brien

N/AItem 4 of the SCHEDULE 13D/A filed 2026-02-11

Swipe the table sideways to see every column.

FTC Solar, Inc.

FTC Solar, Inc. has 1 Schedule 13D or 13G filing on record since 2026-02-13. 1 holder's latest filing reports 5% or more of common stock, $0.0001 par value. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names FTC Solar, Inc., with its principal executive office as 10900 Stonelake Blvd, Suite 100, Quarry Oaks II Building, Austin, TX 78759 (SCHEDULE 13G/A, 2026-02-13).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Genelux Corp

Genelux Corp has 4 Schedule 13D or 13G filings on record since 2025-07-25. 2 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Genelux Corp by CUSIP 36870H103 and gives its principal executive office as 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA 91361 (SCHEDULE 13G/A, 2026-11-04).

See Row 11 of cover page. This percentage is calculated based on 45,245,335 shares of common stock outstanding as of August 11, 2026, as reported in Genelux Corporation's Form 10-Q, filed with the Securities and Exchange Commission on August 13, 2026.Aladar Szalay, SCHEDULE 13G/A, 2026-11-04

Swipe the table sideways to see every column.

Global Gas Corporation

Global Gas Corporation has 3 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of class a common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Global Gas Corporation, with its principal executive office as 700 S. Rosemary Avenue, Suite 204, West Palm Beach, FL 33401 (SCHEDULE 13G/A, 2026-02-12).

Swipe the table sideways to see every column.

Imperial Oil Ltd

Imperial Oil Ltd has 4 Schedule 13D or 13G filings on record since 2025-10-07. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Imperial Oil Ltd by CUSIP 453038408 and gives its principal executive office as 505 QUARRY PARK BOULEVARD S.E., CALGARY (SCHEDULE 13G/A, 2026-11-05).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Instil Bio, Inc.

Instil Bio, Inc. has 2 Schedule 13D or 13G filings on record since 2025-08-12. 1 holder's latest filing reports 5% or more of common stock, $0.000001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Instil Bio, Inc., with its principal executive office as 3963 Maple Avenue, Suite 350, Dallas, TX 75219 (SCHEDULE 13G/A, 2026-02-09).

Swipe the table sideways to see every column.

Jerash Holdings (US), Inc.

Jerash Holdings (US), Inc. has 1 Schedule 13D or 13G filing on record since 2026-02-17. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Jerash Holdings (US), Inc., with its principal executive office as 277 Fairfield Road, Suite 338, Fairfield, NJ 07004 (SCHEDULE 13G/A, 2026-02-17).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Mountain Crest Acquisition Corp. V

Mountain Crest Acquisition Corp. V has 1 Schedule 13D or 13G filing on record since 2026-02-12. 1 holder's latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Mountain Crest Acquisition Corp. V, with its principal executive office as 524 Broadway 11th Floor, New York, NY 10012 (SCHEDULE 13G/A, 2026-02-12).

Mountain Crest Global Holdings LLC and Suying Liu beneficially own 1,865,800 shares of Common Stock. This accounts for 64.94% of the 2,873,023 shares of Common Stock outstanding as of November 14, 2025, as disclosed in the Company's Form 10-Q filed with the SEC on November 14, 2025.Mountain Crest Global Holdings LLC, SCHEDULE 13G/A, 2026-02-12

Swipe the table sideways to see every column.

Mueller Paul Co

Mueller Paul Co has 1 Schedule 13D or 13G filing on record since 2026-02-02. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Mueller Paul Co, with its principal executive office as 1600 W PHELPS ST, P O BOX 828, SPRINGFIELD, MO 65802 (SCHEDULE 13G, 2026-02-02).

Swipe the table sideways to see every column.

Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc. has 2 Schedule 13D or 13G filings on record since 2025-08-15. 1 holder's latest filing reports 5% or more of common stock, $0.0001 par value. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Petros Pharmaceuticals, Inc., with its principal executive office as 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036 (SCHEDULE 13G/A, 2026-02-17).

Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference.Iroquois Capital Management, LLC, SCHEDULE 13G/A, 2026-02-17

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Precipio, Inc.

Precipio, Inc. has 3 Schedule 13D or 13G filings on record since 2025-09-22. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Precipio, Inc., with its principal executive office as 4 SCIENCE PARK, NEW HAVEN, NJ 06511 (SCHEDULE 13G/A, 2026-02-10).

Swipe the table sideways to see every column.

Scantech AI Systems Inc

Scantech AI Systems Inc has 5 Schedule 13D or 13G filings on record since 2025-07-08. 2 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Scantech AI Systems Inc, with its principal executive office as 1735 Enterprise Drive, Buford, GA 30518 (SCHEDULE 13G/A, 2026-02-17).

Swipe the table sideways to see every column.

Scorpius Holdings, Inc.

Scorpius Holdings, Inc. has 3 Schedule 13D or 13G filings on record since 2025-08-05. 1 holder's latest filing reports 5% or more of common stock, par value $0.0002 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Scorpius Holdings, Inc., with its principal executive office as 1305 E. Houston Street, Building 2, San Antonio, TX 78205 (SCHEDULE 13G/A, 2026-02-05).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Tenaris S.A.

Tenaris S.A. has 4 Schedule 13D or 13G filings on record since 2025-07-08. 1 holder's latest filing reports 5% or more of ordinary shares, $1.00 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Tenaris S.A. by CUSIP 88031M109 and gives its principal executive office as 26, BOULEVARD ROYAL, 4TH FLOOR, LUXEMBOURG (SCHEDULE 13D/A, 2026-02-10).

Swipe the table sideways to see every column.

Veru Inc.

Veru Inc. has 2 Schedule 13D or 13G filings on record since 2025-07-16. 1 holder's latest filing reports 5% or more of common stock, $0.01 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing names Veru Inc., with its principal executive office as 2916 N. Miami Avenue, Suite 1000, Miami, FL 33127 (SCHEDULE 13G, 2026-02-17).

Swipe the table sideways to see every column.